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IntroductIon
The	Rh	 blood	 group	 system	 is	 one	 of	 the	most	 im-
portant,	complex	and	immunogenic	systems	known	in	
humans	because	of	its	involvement	in	the	newborn’s	
hemolytic	disease,	 the	 transfusion	 reactions,	and	 the	









mune	destruction	 of	D-positive	 (D+)	 fetal	 red	 cells.	
Since	1968,	with	the	introduction	of	immune	prophy-
laxis	to	prevent	Rhesus	(Rh)D	allo-immunization,	the	
risk	 of	 anti-RhD	 allo-immunization	 has	 been	mark-
edly	reduced	(1	to	6	per	1000	live	births)	4,5.











of	 an	RhD-negative	 fetus6,7.	 In	 this	 study,	we	 deter-
mined	 the	accuracy	of	 the	non-invasive	prenatal	de-
termination	 of	 fetal	 RhD	 genotyping	 by	 the	 use	 of	
real-time	PCR8.
MaterIals and Methods
DNA extraction from plasma samples
Forty	eight	RhD-negative	pregnant	women	in	the	sec-
ond	and	third	trimester	and	six	positive	RhD	samples	
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accuracy.	It	is	therefore	possible	to	consider, that such an assay could be systematically proposed to all RhD-negative pregnant	 	 	 	 	 	 	 	 	 	 	 	 	
women	in	order	to	use RhD prophylaxis more effectively.	 	 	 	
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Real-time PCR for the RHD gene in maternal plasma
The	 procedure	 was	 similar	 to	 that	 previously	 de-
scribed5,8-10.	Amplification	was	carried	out	in	a	Light-	
Cycler	 instrument	(Roche	Biochemicals).	PCR	reac-









































and	 to	 be	 cleared	 rapidly	 following	 delivery.	 With	
the	use	of	real-time	polymerase	chain	reaction	(PCR)	
methodology,	circulating	fetal	DNA	has	been	detect-
ed	 robustly	 in	 the	plasma	of	 pregnant	women,	 even	



















of	 pregnancy.	 Serological	 RhD	 typing	 of	 the	 new-
borns	 showed	 100%	 concordance	 between	 genomic	
and	 serological	 typing.	Among	 the women studied,	 	 	
39.6%	carried	an RhD-negative fetus. In these cases,	 	 	 	 	 	
no	prenatal	anti-D	prophylaxis	is	needed	and	injection	
of	anti-D	immunoglobulin can be avoided. Follow-up	 	 	 	 	
of	pregnancy	is	therefore	made	easier,	decreasing	the	
patient’s	anxiety.
Traditional	 management	 for	 RhD-negative	 preg-
nant	 women	 at	 risk	 for	 RHD	 alloimmunization	 in-
volves	determining	the	RhD	status	of	the	fetus	through	
invasive	chorionic	villus	 sampling	 (CVS)	or	 amnio-
centesis,	 and	 administrating	 the	 prophylactic	 human	
derived	Rho(D)	Immune	Globulin	during	pregnancy	
and	after	delivery.	Both	practices	carry	their	own	risks	
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